Ranked convictions

Conviction Board

The standing calls, ranked by evidence and grouped by horizon. This is the publish gate's whitelisted view — no score internals, no source references, no price levels beyond each call's own invalidation line. What you don't see is the point.

16shown
1 withheld · private-only sourcing
4 citations withheld · private source
board built2026-07-19

Trade

weeks
CoinActionEvidenceConf.Thesis
AERObuy / small
24
lowAERO already broke above the $0.30-$0.50 accumulation range ahead of the July 10-15 ETH exchange launch; confirmed breakout targets $0.60-$0.70.
Invalidation · A daily close back below the $0.45 range top invalidates the breakout and points to a retest of the accumulation range.
CCDCC
TAObuy / small
24
lowLead name of DCC's expected AI rotation (2-3x target); CC wants a dip toward $130 first.
Invalidation · Weekly close below $130 without the AI-rotation catalyst showing up.
DCCCC
HYPEhold
22
lowHYPE's buy signal holds just above $60 with ETF inflows building, but CC flags a weekly close below $60 as the sell-signal trigger to watch.
Invalidation · A weekly close below $60, or BTC breaking under $62K, confirms HYPE's first major sell signal since the $25-30 buy zone.
CCDCC
SOLtrim / small
18
lowSOL sits between $72 support and $85 resistance with no fresh directional call; thin evidence favors trimming the fund's core position now.
Invalidation · Two consecutive weekly closes above $85 would cancel the sell setup and confirm bullish continuation, invalidating this trim.
CCDCC
VVVbuy
12
lowVVV is a dip-watch, not a buy at $11.33: wait for the $8.50-10 zone ($9.50 ideal) before adding any size.
Invalidation · A break below the $8.50 zone floor without holding invalidates the dip-buy plan and reopens the path toward the old $6 level.
CCDCC

Position

months
CoinActionEvidenceConf.Thesis
BTCbuy / small
97
medCycle-theory and quant-risk channels agree BTC stays bullish long-term despite a near-term flush toward $53-56K before a breakout above $67,250.
Invalidation · Thesis breaks on a sustained weekly close below the $53,000 realized-price floor this cycle is expected to hold.
CCDCC
ETHhold
97
medWall Street ETF-driven adoption and steady institutional buying support accumulating ETH as DeFi's foundational asset through this bear market.
Invalidation · The thesis breaks if ETH fails to reclaim its prior all-time high this cycle or treasury accumulation reverses.
CC
AERObuy / small
96
medBullish position play: AERO's Base dominance plus a September Ethereum mainnet catalyst, with price inside CC's $0.45-$0.50 entry pivot.
Invalidation · Thesis breaks on a weekly close below $0.45 support; a further close below $0.40 confirms a deeper breakdown.
CCDCC
ZEChold
90
medZEC's bull setup hinges on a clean July 28 shielded-pool audit reopening a run toward $700-$1,400 from roughly $556 spot.
Invalidation · Thesis breaks if the July 28 audit reveals a dirty shielded-pool print or ZEC closes a week below $200-204.
CCDCC
SOLhold
85
medCC frames SOL as a core buy-and-hold pick for the 2026 accumulation window ahead of the next bull cycle, contingent on winning share versus Base.
Invalidation · Thesis fails on a weekly close below $72 support or if Base decisively wins share from Solana in the L1/DeFi narrative.
CCDCC

Hold

full cycle
CoinActionEvidenceConf.Thesis
ETHhold / medium
88
medHold ETH as a core Wall Street-adoption and treasury-accumulation play through the 2026 accumulation window into the next bull cycle.
Invalidation · The thesis breaks if ETH fails to reclaim its prior all-time high this cycle or treasury-company accumulation reverses.
CC
BTChold / medium
84
medBitcoin's long-term hold thesis stays intact through this consolidation, with both channels treating it as bottoming behavior inside an intact uptrend.
Invalidation · Thesis breaks if BTC loses the ~$53K realized-price floor and slides toward $38K without the MVRV Z-score basing near zero.
DCC
AEROhold / medium
70
medAERO's revenue edge over Uniswap and Tron's liquidity migration to Base position it as an infrastructure-layer bear-market compounder worth holding.
Invalidation · Invalidated by a weekly close back below $0.45 support, or BTC breaking down through its roughly $48K July-low structure.
CCDCC
XLMhold
55
medXLM holds a 13-20c base with DTCC/RWA framed as 2027 fuel, but a 'gives back gains' pattern risks Oct-Nov capitulation to ~10c first.
Invalidation · Invalidation is the DTCC/RWA settlement path failing to materialize, or XLM structurally breaking the ~$0.10-0.13 long base.
CCDCC
DOGEhold / small
53
medCC and DCC both frame DOGE as a long-term DCA hold with cycle upside toward $0.30-$1.50+, but neither sees a fresh buy signal at current support.
Invalidation · Thesis breaks if DOGE loses its shared 5-6c secondary support floor and fails to reclaim it, per both channels' level calls.
CCDCC
XRPavoid
49
medCC's weekly buy signal is canceling with downside toward $1 if BTC's cycle low deepens, and DCC treats Ripple's bank news as color, not a buy signal.
Invalidation · This bearish call is invalidated if XRP reclaims and holds a weekly close above $1.30, confirming the buy signal instead of canceling.
CCDCC

Not financial advice — a research synthesis of public streams. Every conviction carries its own invalidation; verify against the source episodes before acting on anything here.

AI-generated. Produced automatically from public streams; it can contain mistakes. Verify against the original episode before acting.
Built on the free work of Cultivate Crypto· Dollar Cost Crypto· Bob Loukas Go watch the source →